🇺🇸 FDA
Patent

US 11352432

Antibodies specifically binding to human IL-1R7

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 11352432 (Antibodies specifically binding to human IL-1R7) held by MAB Discovery GmbH expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MAB Discovery GmbH
Grant date
Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/505, A61K39/395, A61P, A61P19/02